org placeholder image

Imogen Pryce

Chief Operating Officer, R&D at Relay Therapeutics

  • LinkedIn

Email Email: i****@relaytx.com

phone noPhone Number: (***)-***-****

map
RELAY THERAPEUTICS

RELAY THERAPEUTICS

  • description Description
    Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior re...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 1 Million to 5 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Relay Therapeutics Org Chart and Mapping

Employees

Lauren Weiss

Senior Research Associate

Andre Belperron

Senior Director, Financial Planning & Analysis

Vaishnavi Chavan

Senior Regulatory Affairs Associate

Sándor Babik

Scientist I, Protein Science

Kelly Connolly

Associate Director, Program Management

Matt Delaney

Vice President, Financial Planning & Analysis

Frequently Asked Questions Regarding Imogen Pryce

Answer: Imogen Pryce works for Relay Therapeutics as Chief Operating Officer, R&D

Answer: Imogen Pryce’s role in Relay Therapeutics is Chief Operating Officer, R&D

Answer: Imogen Pryce's email address is i***@gmail.com

Answer: Imogen Pryce's business email address is i****@relaytx.com

Answer: Imogen Pryce’s direct phone number is (***)-***-****

Answer: Imogen Pryce works in the industry of: Biotechnology

Answer: Imogen Pryce works Relay Therapeutics located at 399 Binney St Fl 2, Cambridge, Massachusetts, 02139, United States

Answer: Relay Therapeutics's Chief Operating Officer, R&D is Imogen Pryce

Answer: Imogen Pryce contact details:

  • Phone number  :  (***)-***-****
  • Email  :  i****@relaytx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access